Evidence
- discover-1_2022_rct_meaningful-improvement-in-general-health-outcomes-with-guselkumab-treatment-for-psoriatic-arthritis-patient-reported-outcomes-measurement-information-system-29-results-from-a-phase-3-study
- discover-1_2022_rct_meaningful-improvement-in-general-health-outcomes-with-guselkumab-treatment-for-psoriatic-arthritis-patient-reported-outcomes-measurement-information-system-29-results-from-a-phase-3-study
- discover-1_2022_rct_meaningful-improvement-in-general-health-outcomes-with-guselkumab-treatment-for-psoriatic-arthritis-patient-reported-outcomes-measurement-information-system-29-results-from-a-phase-3-study
- orbai_2022_rct_meaningful-improvement-in-general-health-outcomes-with-guselkumab-treatment-for-psoriatic-arthritis
- orbai_2022_rct_meaningful-improvement-in-general-health-outcomes-with-guselkumab-treatment-for-psoriatic-arthritis
- shippee_2015_cohort_patient-and-caregiver-quality-of-life-early-results-from-the-lifecourse-intervention